HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perianal basal cell carcinoma: a comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus.

Abstract
Perianal basal cell carcinoma is a very rare tumor accounting for only 0.2% of the anorectal tumors. It must be distinguished from basaloid carcinoma of the anus, which resembles it histologically but shows a much more aggressive behavior, metastasizes early, and often proves fatal, thus requiring different therapy. Differential diagnosis of both entities by light microscopy may be difficult. Five cases of perianal basal cell carcinoma and five cases of basaloid carcinoma were studied by means of immunohistochemistry and flow cytometry. Some immunohistochemical markers, such as epithelial membrane antigen, carcinoembrionic antigen, and keratins, as well as the lectin Ulex europaeus agglutinin I stained basaloid carcinoma and were negative for basal cell carcinoma. In contrast, the monoclonal antibody Ber-EP4 seems to be a good marker for perianal basal cell carcinoma and useful in differentiating it from basaloid carcinoma of the anus. Basaloid carcinomas are associated with a significantly higher S-phase fraction than are perianal basal cell carcinomas (p < 0.01).
AuthorsM C Alvarez-Cañas, F A Fernández, I G Rodilla, J F Val-Bernal
JournalThe American Journal of dermatopathology (Am J Dermatopathol) Vol. 18 Issue 4 Pg. 371-9 (Aug 1996) ISSN: 0193-1091 [Print] United States
PMID8879301 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anus Neoplasms (chemistry, immunology, pathology)
  • Carcinoma, Basal Cell (chemistry, immunology, pathology)
  • Carcinoma, Transitional Cell (chemistry, immunology, pathology)
  • DNA, Neoplasm (analysis)
  • Female
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: